<DOC>
	<DOCNO>NCT00973284</DOCNO>
	<brief_summary>The purpose study evaluate efficacy Norwalk virus-like particle ( VLP ) vaccine determine illness rate viral acute gastroenteritis ( AGE ) inpatient stay .</brief_summary>
	<brief_title>Norwalk Vaccine Study</brief_title>
	<detailed_description>The drug test study call intranasal Norwalk virus-like particle ( VLP ) vaccine . Norwalk VLP vaccine test prevent viral acute gastroenteritis ( AGE ) . This study look illness rate AGE people administer Norwalk VLP vaccine . The study enrol 98 patient conduct 2 stage : Vaccination Stage Challenge Stage . In Vaccination Stage participant randomly assign ( chance , like flip coin ) one two treatment groups—which remain undisclosed patient study doctor study ( unless urgent medical need ) : - Norwalk VLP Vaccine ( 100 µg VLP ) intranasally - Placebo ( dummy inactive powder ) - powder look like study drug active ingredient During Challenge Stage participant administer live Norwalk virus monitor AGE . This multi-center trial conduct United States . The overall time participate study 29 week Participants make multiple visit clinic contact telephone 6 month last dose study drug follow-up assessment .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<criteria>1 . Signed informed consent . 2 . Age 18 50 year , inclusive . 3 . Good general health determine screen evaluation within 45 day randomization . 4 . Expressed interest , availability , understand fulfill study requirement include measure prevent Norwalk virus contamination environment spread infection illness community . The prospective subject must pass ( &gt; 75 % correct answer ) write examination aspect study enrollment . ( Appendix D ) 5 . Available return followup visit follow discharge inpatient unit deliver stool specimen investigator promptly . 6 . Female subject must nonchildbearing potential , childbearing potential ( determined investigator ) must practice abstinence use effective license method birth control ( e.g . oral contraceptive ; diaphragm condom combination contraceptive jelly , cream , foam ; intrauterine contraceptive device , DepoProvera ; skin patch ; vaginal ring cervical cap ) 30 day prior vaccination must agree continue precaution study 60 day Challenge visit . Male subject must agree father child study 60 day Challenge visit . 7 . Demonstrated H type1 antigen secretor positive ( saliva test ) . [ This saliva test may do outside 45 day window need repeat . ] 8 . Agrees participate another clinical trial investigational product entire duration study ( six month last dose study vaccine placebo i.e . 201 day ) . 1 . Living daily contact child age 5 year less woman know pregnant . This include significant contact home , school , daycare , equivalent facility . 2 . Nursing mother . 3 . Living daily contact childcare worker . 4 . Living daily contact elderly person age 70 year , infirmed , diapered individual , person disability incontinent person . This include work visit nurse home daycare equivalent facility . 5 . Evidence recent ( within 2 month ) current nonbacterial gastroenteritis suggestive Norwalk virus infection [ vomiting unformed watery stool ( &gt; 2 24 hour period ) ] . 6 . Any gastroenteritis within past 2 week . 7 . History chronic functional dyspepsia , chronic gastroesophageal reflux disease , peptic ulcer disease , gastrointestinal hemorrhage , gall bladder disease , inflammatory bowel disease , irritable bowel syndrome , frequent diarrhea , chronic constipation , diverticulitis anytime subject 's lifetime . 8 . Regular use medication oral contraceptive agent , antihypertensive , antidepressant , vitamin mineral . 9 . History follow medical illness : Chronic rhinitis , runny nose , sneeze ( include seasonal allergy ) Clinically significant nose bleed within prior 12 month Diabetes Cancer ( malignancy resolve skin lesion ) Heart disease ( hospitalization heart attack , arrhythmia , syncope ) Unconsciousness ( single brief `` concussion '' ) Seizures ( febrile seizure child &lt; 5 year old ) Asthma require treatment inhaler medication prior 2 year Neuroinflammatory disease Autoimmune disease Eating disorder Chronic headache associate vomit Chronic vomit syndrome 10 . Any current illness require daily medication vitamin , mineral , birth control , antidepressants antihypertensive . 11 . Blood Type B AB . [ This blood test may do outside 45 day window need repeat . ] 12 . Allergies hypersensitivity chitosan , shrimp , shellfish component vaccine placebo . 13 . History nasal surgery type ( include tonsillectomy adenoidectomy ) . 14 . Any clinically significant abnormality detect physical examination , include : Murmur ( functional murmur ) Focal neurological abnormality Hepatosplenomegaly Lymphadenopathy Jaundice 15 . Hypertension define BP &gt; 150/90 mm Hg two separate measurement . Chronic stable wellcontrolled hypertension medication allow . 16 . History 3 hospitalization invasive bacterial infection ( pneumonia , meningitis ) , acute chronic dermatitis ( e.g . eczema , seborrhea , psoriasis ) collagen vascular disease [ e.g . systemic lupus erythematosus ( SLE ) dermatomyositis ] . 17 . Presence serious chronic illness ( i.e . malignancy resolve skin lesion ) . 18 . Positive stool/fecal culture bacterial pathogen ( salmonella , campylobacter , E. coli 0157 : H7 , shigella ) positive stool/fecal screen ovum parasite . 19 . Employment food service industry , restaurant , cafeteria facility . Specifically , include person whose employment require food process 4 week follow challenge . 20 . Healthcare worker patient contact expect 4 week follow challenge . 21 . Expected contact ( employment home ) immunocompromised person ( HIVpositive , receive immunosuppressive medication oral steroid , antineoplastic agent ) 4 week follow challenge . 22 . Employment airline flight attendant , schedule work 4 week follow challenge . 23 . Persons plan take cruise 4 week follow challenge . 24 . Persons consume plan consume raw shellfish ( e.g . oyster ) within 7 day prior enrollment throughout study . 25 . Any following lab abnormality : Absolute neutrophil count ( ANC ) total white blood cell ( WBC ) outside normal range ( may repeat outside limit ) Hemoglobin outside normal range ( may repeat outside limit ) Platelet count outside normal range ( may repeat outside limit ) Electrolytes , blood urea nitrogen ( BUN ) and/or creatinine outside normal range ( may repeat outside limit ) Glucose &gt; upper limit normal ( ULN ) ( may repeat outside limit ) . Fasting glucose require . Alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) , alkaline phosphatase , bilirubin ( total indirect ) gamma glutamyl transferase ( GGT ) outside normal range ( may repeat outside limit ) Positive serology hepatitis C human immunodeficiency virus ( HIV ) antibody hepatitis B surface antigen rapid plasma reagin ( RPR ) 26 . For woman , positive serum pregnancy test within 14 day positive urine pregnancy test within 24 hour randomization . 27 . Temperature &gt; 99.7°F orally symptom acute selflimited illness upper respiratory infection gastroenteritis within 3 day randomization . 28 . Previous participation study experimental norovirus infection vaccine . 29 . Study site personnel family member . 30 . Significant history psychiatric hospitalization , alcohol abuse , illicit drug use . 31 . Receipt license live vaccine within 28 day license inactivated vaccine within 14 day randomization . 32 . Completion investigational vaccine drug study within 28 day randomization . 33 . Other condition clinical judgment investigator would jeopardize safety right subject participate trial , would render subject unable comply protocol would interfere evaluation vaccination stage evaluation challenge stage .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Prevention acute gastroenteritis due infection experimental Norwalk Virus</keyword>
</DOC>